Intercept Pharmaceuticals (ICPT) PT Raised to $146 at Wells Fargo
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ICPT Hot Sheet
Price: $19.00 --0%
Rating Summary:
13 Buy, 17 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Rating Summary:
13 Buy, 17 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Join SI Premium – FREE
Wells Fargo analyst Jim Birchenough raised the price target on Intercept Pharmaceuticals (NASDAQ: ICPT) to $146.00 (from $120.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Modine Manufacturing (MOD) PT Lowered at KeyBanc on 'Margin Headwinds'
- Walt Disney (DIS) PT Raised to $133 at Morgan Stanley
- Camping World Holdings (CWH) PT Lowered at KeyBanc on 'Miss, End Market Headwinds'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
